# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hepatitis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 451-460 of 495 results.
Atezolizumab Plus Bevacizumab With HCC and HBV Infection
Status: Not yet recruiting
Last Changed: Nov 27, 2019
First Received: Nov 27, 2019
Disease(s): HCC and HBV Infection
Intervention(s): Atezolizumab plus bevacizumab
A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GB1211 in Healthy Subjects and in Subjects With Suspected Non-Alcoholic Steato-Hepatitis (NASH) and Liver Fibrosis
Status: Recruiting
Last Changed: Jan 24, 2019
First Received: Jan 18, 2019
Disease(s): Safety and Tolerability
Intervention(s): GB1211, Placebo
Locations: (For Parts A and B) Covance Clinical Research Unit Ltd, Leeds, United Kingdom
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
Status: Recruiting
Last Changed: Oct 14, 2020
First Received: May 21, 2020
Disease(s): Pneumococcal Immunisation, Diphtheria Immunisation, Tetanus Immunisation, Pertussis Immunisation, Hepatitis B Immunisation, Haemophilus Influenzae Type b Immunisation, Polio Immunisation, Measles Immunisation, Rubella Immunisation, Varicella Immunisation, Mumps Immunisation
Intervention(s): SP0202-IIb Pneumococcal Conjugate Vaccine formulation 1, SP0202-VI Pneumococcal Conjugate Vaccine formulation 2, SP0202-VII Pneumococcal Conjugate Vaccine formulation 3, Varicella Virus Vaccine Live, Measles, Mumps, and Rubella Virus Vaccine Live, Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate), Rotavirus Vaccine, Live, Oral, Pentavalent, Hepatitis B Vaccine [Recombinant]
Locations: Investigational Site Number 8400040, Bellflower, California, United States
Investigational Site Number 8400030, Huntington Park, California, United States
Investigational Site Number 8400058, Huntington Park, California, United States
Investigational Site Number 8400059, Los Angeles, California, United States
Investigational Site Number 8400060, Ontario, California, United States
... and 28 other locations.
NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC
Status: Recruiting
Last Changed: Jul 02, 2020
First Received: May 28, 2020
Disease(s): HBV/HCV Co-infection
Intervention(s): 24-week Entecavir, 12-week Entecavir
Locations: National Taiwan University Hospital, Taipei City, Taiwan
TC Chen, Taipei, Taiwan
Effect of Some Drugs on Liver Fibrosis
Status: Recruiting
Last Changed: Dec 10, 2018
First Received: Dec 10, 2018
Disease(s): Liver Fibroses
Intervention(s): Candesartan, Ramipril
Locations: Sherief Abd-Elsalam, Tanta, Egypt
Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA
Status: Recruiting
Last Changed: Sep 04, 2020
First Received: Sep 04, 2020
Disease(s): B-cell Lymphoma, HBV
Intervention(s): Tenofovir, Entecavir
Locations: Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Carvedilol for Prevention of Esophageal Varices Progression
Status: Recruiting
Last Changed: Nov 09, 2018
First Received: Nov 09, 2018
Disease(s): Cirrhosis, Liver, Portal Hypertension
Intervention(s): Carvedilol
Locations: Beijing Ditan Hospital Capital Medical University, Beijing, Beijing, China
Peking University First Hospital, Beijing, Beijing, China
Peking University People's Hospital, Beijing, Beijing, China
Beijing Friendship Hospital, Beijing, Beijing, China
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
... and 2 other locations.
Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs
Status: Not yet recruiting
Last Changed: Feb 05, 2019
First Received: Jan 29, 2019
Disease(s): HCV
The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC
Status: Not yet recruiting
Last Changed: Oct 29, 2018
First Received: Oct 29, 2018
Disease(s): Hepatocellular Carcinoma
Intervention(s): MMP1 genotypes polymorphism
Pembrolizumab in Hepatocellular Carcinoma
Status: Recruiting
Last Changed: Dec 04, 2020
First Received: Feb 05, 2018
Disease(s): HCC
Intervention(s): pembrolizumab
Locations: Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong